Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774797 · ClinicalTrials.gov registry record
Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
A clinical trial of Pregnancy Related, sponsored by University of Michigan.
- Completed
- Registry status
- 592
- Enrollment target
- 1
- Study location
NCT03774797 is a study of Pregnancy Related that has completed, run by University of Michigan. The registered enrollment target is 592 participants, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03774797, a study of Pregnancy Related, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 592 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women who desire it.
Conditions Studied
Interventions
- OTHER Implementation Toolkit
Study Locations (1)
Michigan
- Michigan Medicine - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03774797
The ClinicalTrials.gov registry entry for NCT03774797 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 592 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (70% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Implementation Toolkit is the first listed.
NCT03774797 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03774797 about?
NCT03774797 is a clinical study titled "Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation". The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women w...
What is the current status of trial NCT03774797?
This trial is currently completed. The enrollment target is 592 participants. The study started on 2018-09-01. Estimated completion is 2020-08-16.
What conditions does trial NCT03774797 study?
This clinical trial studies the following conditions: Pregnancy Related.
What interventions are being tested in trial NCT03774797?
The interventions under investigation include: Implementation Toolkit (OTHER).
Who is sponsoring clinical trial NCT03774797?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03774797 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.